ConductScience.org, home

Gene · 474

NIH grants1,517

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleATOH1 papersNewest fiscal year
R01DC013294Modeling Inner Ear Differentiation with Pluripotent Stem Cells22025
R01DC014718Transcriptional networks establishing the precise gene expression states that define neurosensory cell identity in the inner ear22025
R01DC016099Inner ear ion channels in healthy and diseased conditions22025
R01DC019619Regenerative pathways in the avian cochlea22025
R35CA197570Early to Late Events in Colorectal Neoplasia: Basic Biology to Clinical Implementation22025
R35CA210807Defining Drivers of HPV-associated Carcinogenesis22025
R35CA231997Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies22025
R35GM122465Probing Tissue Heterogeneity and Stem Cell Niche with Micro-Organospheres22025
T32CA009302Leveraging innovative technologies in basic and clinical cancer research22025
T32CA119925Integrated Biological Systems Training in Oncology22025
T32CA128583Research Training in Childhood Cancer22025
T32DK007130Clinical/Laboratory Training Academic Gastroenterology22025
T32GM007748Training Grant in Genetics22025
T32HL007901Training in Sleep, Circadian, and Respiratory Neurobiology22025
T32NS076401Early Stage Training in the Neurosciences22025
U01CA200466Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma22025
U01HG011762Stanford Mendelian Genomics Research Center22025
ZIAAR041222Molecular pathogenesis and therapy innovation for Merkel cell carcinoma22025
ZIABC011793Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies22025
ZIADE000695Adeno-associated Virus Biology And Utilization For Gene Transfer22025

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/474/grants?page=4